Skip to main content
. 2023 Feb 14;13(9):5609–5618. doi: 10.1039/d2ra06859a

Fig. 3. The relative cell activity of 4T1 cells treated with different nanodrugs for different times. (a) HHSA, 12 h; (b) HHSA, 24 h; (c) HHSA@Ce6, 12 h; (d) HHSA@Ce6, 24 h. The concentration of different nanocapsules was calculated according to the concentration of HHSA.

Fig. 3